Tolvaptan (Samsca)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Tolvaptan (Samsca), covering 2025-03-25 to 2025-09-10. Get the full timeline:
Most recent: Clinical Trial Update: Single Dose of 7.5mg Tolvaptan Phase I Clinical Trial Protocol [Phase 1]